PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatic encephalopathy |
| Phenotype | C0023890|liver cirrhosis |
| Sentences | 30 |
| PubMedID- 25060166 | Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted mr imaging and proton mr spectroscopy of the brain. |
| PubMedID- 23414576 | In pharmacological therapy, ornithine is used to decrease blood ammonia concentrations and reduce the symptoms of hepatic encephalopathy associated with liver cirrhosis[6]. |
| PubMedID- 25420740 | Herein, we report a case of cryptococcal meningitis mimicking hepatic encephalopathy in a patient with liver cirrhosis. |
| PubMedID- 20852922 | The mean cff was higher in patients after liver transplantation, but did not reach statistical significance.table 2surrogate markers for hepatic encephalopathy in patients with liver cirrhosis and those who have received liver transplants. |
| PubMedID- 21416318 | Pylori) bacteria convert urea to ammonia, which has been implicated in causation of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 24709242 | Objective: to determine the efficacy of rifaximin in prevention of repeated episodes of hepatic encephalopathy in patients with liver cirrhosis as compared to placebo. |
| PubMedID- 22791641 | Cognitive evoked response potentials in patients with liver cirrhosis without diagnosis of minimal or overt hepatic encephalopathy. |
| PubMedID- 25100119 | Conclusion: probiotics decrease overt hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 20216550 | Increased blood-brain barrier (bbb) permeability for ammonia is considered to be an integral part of the pathophysiology of hepatic encephalopathy (he) in patients with liver cirrhosis. |
| PubMedID- 24078984 | Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 23742732 | Prospective randomized clinical trials that compared the effects of zinc supplementation with those of no intervention, placebo, or standard therapy on hepatic encephalopathy in patients with liver cirrhosis were included. |
| PubMedID- 25509200 | The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 20934771 | Conclusions: sedation with propofol has a shorter time recovery and a shorter time to discharge than midazolam and does not exacerbate sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis. |
| PubMedID- 20642112 | Low doses are used as a food supplement and high doses (above 5 g) as a medicinal product to lower blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis. |
| PubMedID- 22870180 | Here we report on a patient suffered from liver cirrhosis with recurrent hepatic encephalopathy who developed mnz-induced neurotoxicity. |
| PubMedID- 21757988 | He had been hospitalized several times for alcoholic liver cirrhosis with hepatic encephalopathy. |
| PubMedID- 23225825 | Previously studies have investigated the effect of propofol on sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis.11,18 these studies found that propofol sedation during upper gastrointestinal endoscopy did not cause acute deterioration of sub-clinical hepatic encephalopathy.11,18 however, in patients with liver cirrhosis, hepatic function reserve is quite limited, and a cirrhotic liver is less tolerant to hemodynamic changes and surgical stress.1 therefore, anesthetic agents should be titrated with caution in cirrhotic patients to minimize the adverse effects of drugs and to stabilize hemodymanics. |
| PubMedID- 21483460 | 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 23967390 | Furthermore, it is used for prophylaxis of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 25867912 | Objective: to determine the efficacy of rifaximin once a day dose in the prevention of hepatic encephalopathy (he) in patients with liver cirrhosis as compared with twice daily dose of rifaximin. |
| PubMedID- 26516441 | In our study, hyponatremia was associated with increased incidence of hepatic encephalopathy in patients with decompensated liver cirrhosis. |
| PubMedID- 24974838 | Infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension. |
| PubMedID- 22384773 | Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis. |
| PubMedID- 25847088 | Aim: to examine whether the brain exhibits metabolic disorder prior to overt hepatic encephalopathy in patients with liver cirrhosis (lc), the intracerebral glutamine and myo-inositol levels were determined using 3.0-tesla (t)1 h (proton) magnetic resonance spectroscopy (mrs). |
| PubMedID- 20482828 | Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin ii receptor blocker combination therapy: a case report. |
| PubMedID- 25459346 | Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes. |
| PubMedID- 20010298 | Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 23626595 | Even if a patient has liver cirrhosis with hepatic encephalopathy, liver cirrhosis should not be considered to be the only cause of hyperammonemia. |
| PubMedID- 25863779 | Patients with hepatic encephalopathy in liver cirrhosis and healthy controls ingested a 20-g solution of glutamine dissolved in 100 ml of tap water. |
| PubMedID- 25932262 | Aim: to determine the effects of small-intestinal bacterial overgrowth (sibo) and rifaximin therapy on minimal hepatic encephalopathy (mhe) with liver cirrhosis. |
Page: 1